| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.12 | 0.5 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |